Delivery Order SPE2DB22D3016-SPE2DB25FBDW2
Award Date 8/4/25
Potential Completion Date 8/25/25
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count package), with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed from the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (quantity 28) under a firm fixed-price contract. The order, valued at $7,575.75, was competitively awarded without a set-aside designation and is scheduled for completion by August 8, 2025. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Imbruvica 70 mg capsules (28-count units) with a contract value of $7,575.75. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The award was made through open competition with no set-aside designation, and the place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,575.75 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count units) with delivery to Conshohocken, Pennsylvania. This contract, awarded on August 4, 2025, utilizes a firm fixed-price structure with an ultimate completion date of August 25, 2025. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors. This delivery order represents a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,151.52 on July 24, 2025, for the supply of Imbruvica 280 mg tablets (28-count packaging) to support federal medical procurement needs. The contract carries a firm fixed price structure and is not set aside for any particular business category. Performance is scheduled for completion by August 14, 2025, with work being conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,467.48 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 140 mg capsules (90-count units). This firm fixed-price, competitively awarded delivery order carries an ultimate completion date of August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, demonstrating AmerisourceBergen's continued capability to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Imbruvica 140 mg tablets. The $7,322.67 order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, provides a range of pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order is part of Amerisourcebergen's...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide IMBRUVICA 280 MG TABLET 28S. The contract has a potential value of $7,322.67 and a completion date of March 4, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $7,322.67 by the Defense Logistics Agency Troop Support Medical to supply IMBRUVICA 420 MG tablets. Performance will take place in Conshohocken, Pennsylvania under contract 4561327435 from June 23, 2023 through July 17, 2023. The Defense Logistics Agency Troop Support Medical utilizes indefinite-delivery/indefinite-quantity contracts to support the medical...
- The Defense Logistics Agency Troop Support Medical awarded a $14,645 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 tablets of the pharmaceutical IMBRUVICA 280 MG. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on September 11, 2023 through October 2, 2023. No major subcontractors or set aside designations were indicated. This delivery order was issued under...